Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells

被引:12
|
作者
Mamata, Y [1 ]
Hakki, A [1 ]
Yamamoto, Y [1 ]
Newton, C [1 ]
Klein, TW [1 ]
Pross, S [1 ]
Friedman, H [1 ]
机构
[1] Univ S Florida, Dept Med Microbiol & Immunol, Coll Med, Tampa, FL 33612 USA
关键词
nicotine; TGF-beta; 1; Chlamydia pneumoniae; TNF-alpha; IL-10; IL-12; PBMC;
D O I
10.1016/j.intimp.2004.12.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nicotine, the addictive component of cigarette smoke, has been shown to have immunomodulatory effects. This drug alters proinflammatory cytokine production by immune cells, including lymphocytes, monocytes, and macrophages. The present study focuses on the effects of nicotine on infection by Chlamydia pneumoniae (Cpn), a ubiquitous intracellular pathogen which causes acute and chronic inflammatory diseases such as pulmonary infections, and may be associated with arthritis and atherosclerosis. Previous studies in our laboratory showed that lymphocytes and macrophages are susceptible to Cpn infection. The present study aimed at investigating the effect of nicotine on TGF-beta1, IL- 10, IL- 12, and TNF-alpha production in Cpn-infected human peripheral blood mononuclear cells (PBMCs). Cytokine levels in the supernatant were assessed by ELISA. The results showed that Cpn infection alters the expression levels of IL-10, IL-12, and TNF-alpha in a time-dependent fashion. Nicotine treatment of the Cpn-infected cells up-regulated IL-10, but not TNF-alpha and IL-12, and also resulted in significant down-regulation of TGF-beta1 production which was marked in the Cpn-infected control cells. The combined action of nicotine and Cpn on cytokine production may have an impact in chronic inflammatory diseases. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 50 条
  • [1] Chlamydia pneumoniae infection of human immune cells modulates cytokine production.
    Mamata, Y
    Newton, C
    Klein, TW
    Yamamoto, Y
    Friedman, H
    CLINICAL IMMUNOLOGY, 2005, 115 : S159 - S159
  • [2] Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells
    Netea, MG
    Selzman, CH
    Kullberg, BJ
    Galama, JMD
    Weinberg, A
    Stalenhoef, AFH
    Van der Meer, JWM
    Dinarello, CA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (02) : 541 - 549
  • [3] Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
    KaukorantaTolvanen, SSE
    Teppo, AM
    Laitinen, K
    Saikku, P
    Linnavuori, K
    Leinonen, M
    MICROBIAL PATHOGENESIS, 1996, 21 (03) : 215 - 221
  • [4] Chlamydia pneumoniae infection modulates cytokine production by human T lymphocytes and monocytes
    Hakki, Amal
    Mamata, Yukimitsu
    Friedman, Herman
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [5] Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells
    Chorazy, M
    Kontny, E
    Marcinkiewicz, J
    Maslinski, W
    AMINO ACIDS, 2002, 23 (04) : 407 - 413
  • [6] Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells
    M. Chorąży
    E. Kontny
    J. Marcinkiewicz
    W. Maśliński
    Amino Acids, 2002, 23 : 407 - 413
  • [7] Growth in vascular cells and cytokine production by Chlamydia pneumoniae
    Gaydos, CA
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S473 - S478
  • [8] Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells
    Wolf, K
    Fischer, E
    Hackstadt, T
    INFECTION AND IMMUNITY, 2005, 73 (08) : 4560 - 4570
  • [9] Azithromycin Treatment Modulates Cytokine Production in Chlamydia trachomatis Infected Women
    Srivastava, Pragya
    Jha, Hem Chandra
    Salhan, Sudha
    Mittal, Aruna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 478 - 482
  • [10] Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia
    Jansky, L
    Reymanová, P
    Kopecky, J
    PHYSIOLOGICAL RESEARCH, 2003, 52 (05) : 593 - 598